XML 38 R28.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
 6 Months Ended
Dec. 27, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Options
The following table summarizes activity of the Company's stock option plans since June 28, 2024:
Options Outstanding
Number of
Shares		Weighted Average
Grant Date
Fair Value		Weighted Average
Exercise Price		Weighted Average
Remaining
Contractual Term
(Years)		Aggregate
Intrinsic Value as of December 27, 2024
Outstanding at June 28, 2024934 $12.71 $45.00 — 
Granted— — 
Exercised— — 
Canceled— — 
Outstanding at December 27, 2024934 12.71 45.00 3.21 years— 
Exercisable at December 27, 2024— $— $— — — 
Schedule of Restricted Stock Awards
The following table summarizes the status of the Company’s non-vested restricted stock awards and deferred stock awards since June 28, 2024:
 Non-vested Restricted Stock Awards
 Number of
Shares		Weighted Average
Grant Date
Fair Value
Outstanding at June 28, 20241,526 $41.35 
Granted873 39.82 
Vested(292)43.47 
Forfeited(97)43.65 
Outstanding at December 27, 20242,010 $39.68 
Schedule of Stock-Based Compensation Expense
The following table presents share-based compensation expenses included in the Company’s Consolidated Statements of Operations and Comprehensive Loss:

 Second Quarters EndedSix Months Ended
 December 27, 2024December 29, 2023December 27, 2024December 29, 2023
Cost of revenues$(167)$4 $(54)$820 
Selling, general and administrative6,317 5,742 10,928 7,503 
Research and development1,812 1,640 3,180 3,180 
Stock-based compensation expense before tax7,962 7,386 14,054 11,503 
Income taxes(1)
(2,150)(1,994)(3,795)(3,106)
Stock-based compensation expense, net of income taxes$5,812 $5,392 $10,259 $8,397 
(1) Federal and state statutory rate of 27%